Inspire HGNS denied due to quantity / dose limits by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for inspire hgns are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Limits the Inspire HGNS System — and Why You Can Appeal

Blue Cross Blue Shield applies quantity or unit limits to implantable neurostimulation devices because each policy defines exactly how many components (e.g., generator, lead, programmer) are covered per episode of care or per lifetime. A denial citing quantity limits usually means the claim was coded in a way that appeared to exceed those defined units, or a replacement or revision procedure was not linked clearly enough to a documented clinical reason.

This denial is appealable. The device is FDA-approved for obstructive sleep apnea (OSA) in patients who meet specific criteria, and a quantity-limit denial is a coverage-mechanics dispute — not a clinical rejection — making it well-suited for appeal.

## Federal Appeal Rights

Under ACA §2719 and its implementing regulations, non-grandfathered individual and group plans must provide at least two internal appeal levels and access to independent external review. ERISA §503 entitles participants in employer-sponsored plans to a full-and-fair review. The external-review window is generally 180 days from the denial notice (verify the exact deadline on your Explanation of Benefits). An expedited review — with a decision typically within 72 hours — is available when a standard timeline would seriously jeopardize your health.

## Concrete Appeal Process

1. Request the denial rationale in writing and obtain BCBS's current medical policy and coverage criteria for hypoglossal nerve stimulation. 2. File a Level 1 internal appeal within the deadline shown on your denial letter. Include a letter from your surgeon or sleep medicine physician explaining the number of units required and why each is medically necessary. 3. If denied again, file a Level 2 internal appeal, then escalate to independent external review through your state's insurance commissioner or the federal External Review Program.

## Documentation to Gather

• Diagnosis confirmation: Polysomnography (sleep study) report documenting severity of OSA and relevant findings, signed by a board-certified sleep medicine specialist.
• Prior-treatment history: Dated records of CPAP or BiPAP trials, duration, adherence data, and reasons for inadequacy or failure.
• Clinical severity: Physician notes summarizing functional impairment, cardiovascular risk, and quality-of-life burden from untreated OSA.
• Operative and billing records: Surgical report itemizing each component implanted, with corresponding HCPCS/CPT codes, to show the claimed units match what was actually placed.
• Medical-necessity letter: A specific statement from the implanting surgeon that each billed unit is a required, distinct component of a single device system — not a duplicate.

## Criteria-Mapping Structure

Pull BCBS's published medical policy for hypoglossal nerve stimulation and list every coverage criterion. For each criterion, document the exact chart fact that satisfies it. Then map each billed code to the device component it represents and show that the total units match the FDA-cleared device configuration. This one-to-one mapping is the core of a successful quantity-limit appeal.